» Articles » PMID: 7772061

Intimal Thickenings of Human Aorta Contain Modified Reassembled Lipoproteins

Overview
Journal Atherosclerosis
Publisher Elsevier
Date 1995 Jan 6
PMID 7772061
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to determine whether in human aortas early minute changes such as minimal intimal thickenings (MIT), developed in areas known to have a predilection to atherosclerosis, contain modified reassembled lipoproteins (MRLp) such as extracellular liposomes (EL) and lipid droplets (LD). These features have been previously detected in the aortic lesion-prone areas of rabbits and hamsters fed a fat-rich diet. Tissue samples of the aortic arch and thoracic aorta from 12 young subjects who died in accidents were selectively collected from grossly normal regions. By light microscopy, some of these regions were found to contain MIT. The normal areas and the MIT were separately examined by electron microscopy or subjected to fractionation and partial biochemical characterization. The MIT (approximately 25-100 microns thick) were constituted by a pronounced proliferation of extracellular matrix, especially elastin and microfibrils, with interspersed lipid deposits appearing as EL and LD. Commonly, MIT did not contain smooth muscle cells, macrophages, foam cells or cytolytic debris. Such components were only occasionally found in specimens excised from the vicinity of fatty streaks. Saline extracts of MIT or grossly normal aortic regions were subjected to a four-step purification procedure consisting of gel filtration, affinity chromatography on anti-apo B and anti-albumin Sepharose, followed by density gradient ultracentrifugation. The entire procedure was monitored by negative staining, lipid assays, SDS PAGE and immunoblotting. From the initial MRLp mixture, two fractions were obtained: fraction 1 containing multilamellar EL and LD, and fraction 2 composed mostly of unilamellar EL. As compared with serum LDL, the cholesteryl ester/unesterified cholesterol ratio was 4-6-fold lower in fraction 1 and 15-19-fold lower in fraction 2. On SDS-PAGE the fraction 2 displayed a single protein band of 66 kDa, immunochemically identified as albumin. The MRLp isolated from human aortas with minimal intimal thickenings appeared to be similar to those purified from the prelesional stage aorta of hyperlipidemic rabbits and hamsters.

Citing Articles

Synthetic lipoproteins based on apolipoprotein E coupled to fullerenol have anti-atherosclerotic properties.

Tudorache I, Bivol V, Dumitrescu M, Fenyo I, Simionescu M, Gafencu A Pharmacol Rep. 2022; 74(4):684-695.

PMID: 35790693 DOI: 10.1007/s43440-022-00379-8.


Chitosan Nanoparticles in Atherosclerosis-Development to Preclinical Testing.

Sriamornsak P, Dass C Pharmaceutics. 2022; 14(5).

PMID: 35631521 PMC: 9145436. DOI: 10.3390/pharmaceutics14050935.


Extracellular Vesicles: Versatile Nanomediators, Potential Biomarkers and Therapeutic Agents in Atherosclerosis and COVID-19-Related Thrombosis.

Georgescu A, Simionescu M Int J Mol Sci. 2021; 22(11).

PMID: 34073119 PMC: 8198837. DOI: 10.3390/ijms22115967.


Aggregation Susceptibility of Low-Density Lipoproteins-A Novel Modifiable Biomarker of Cardiovascular Risk.

Oorni K, Kovanen P J Clin Med. 2021; 10(8).

PMID: 33921661 PMC: 8074066. DOI: 10.3390/jcm10081769.


Role of Macrophages and RhoA Pathway in Atherosclerosis.

Kloc M, Uosef A, Kubiak J, Ghobrial R Int J Mol Sci. 2020; 22(1).

PMID: 33379334 PMC: 7796231. DOI: 10.3390/ijms22010216.